Wilfred van der Donk

Department of Chemistry
University of Illinois at Urbana-Champaign
Howard Hughes Medical Institute, Urbana
Thursday, Nov. 30, 2017 4:30pm
Edward C. Taylor Auditorium, Frick B02
Host
Mohammad Seyedsayamdost
Add to Calendar2017-11-30 16:30:002017-11-30 16:30:00Mohammad SeyedsayamdostEdward C. Taylor Auditorium, Frick B0215YYYY-MM-DD

BIOSYNTHESIS AND ENGINEERING OF CYCLIC PEPTIDE ANTIBIOTICS

The genome sequencing efforts of the first decade of the 21st century have revealed that ribosomally synthesized and post-translationally modified peptides (RiPPs) constitute a very large class of cyclic peptide natural products. These molecules are produced in all three domains of life, their biosynthetic genes are ubiquitous in the currently sequenced genomes, and their structural diversity is vast. Lanthionine-containing peptides (lanthipeptides) are examples of this growing class and many members are highly effective peptide-derived antimicrobial agents that display nanomolar minimal inhibitory concentrations (MICs) against pathogenic bacteria (lantibiotics). These peptides are post-translationally modified to install multiple thioether crosslinks. During their biosynthesis, a single enzyme typically breaks 8-16 chemical bonds and forms 6-10 new bonds with high control over regio- and chemoselectivity. After installation of the crosslinks, tailoring reactions often decorate the final product. This presentation will discuss investigations of the mechanisms of these remarkable catalysts as well as their use for the generation of non-natural cyclic peptide libraries, and their use to disrupt protein-protein interactions.

 

 

Share
Research Areas